000 01194 a2200313 4500
005 20250512040125.0
264 0 _c19850426
008 198504s 0 0 eng d
022 _a0167-6806
024 7 _a10.1007/BF01807655
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aUmbach, G E
245 0 0 _aMedroxyprogesterone acetate does not protect human bone marrow progenitor cells exposed to adriamycin in vitro.
_h[electronic resource]
260 _bBreast cancer research and treatment
_c1985
300 _a87-9 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S.
650 0 4 _aBone Marrow
_xdrug effects
650 0 4 _aDoxorubicin
_xtoxicity
650 0 4 _aHematopoietic Stem Cells
_xdrug effects
650 0 4 _aHumans
650 0 4 _aMedroxyprogesterone
_xanalogs & derivatives
650 0 4 _aMedroxyprogesterone Acetate
700 1 _aSpitzer, G
700 1 _aDrewinko, B
700 1 _aGercovich, G
700 1 _aHortobagyi, G
773 0 _tBreast cancer research and treatment
_gvol. 5
_gno. 1
_gp. 87-9
856 4 0 _uhttps://doi.org/10.1007/BF01807655
_zAvailable from publisher's website
999 _c3162433
_d3162433